Results 171 to 180 of about 22,161 (255)

Glycaemic penalty index as an independent predictor of healthcare‐associated infection in surgical inpatients: A nested cohort study from the STOIC‐D surgery trial

Diabetic Medicine, EarlyView.
Higher glycaemic burden, measured by the Glycaemic Penalty Index (GPI), was independently associated with increased risk of healthcare‐associated infection in surgical inpatients. GPI provides a single, clinically interpretable summary of both hyperglycaemia and hypoglycaemia. Abstract Aims To evaluate the utility of the Glycemic Penalty Index (GPI), a
Gabrielle Blomson, Rahul D. Barmanray, Mervyn Kyi, Peter G. Colman, Leon J. Worth, Minh V. Le, Emily Sun, Spiros Fourlanos   +7 more
wiley   +1 more source

Association of Food-Specific Glycemic Load and Distinct Dietary Components with Gestational Diabetes Mellitus Within a Mediterranean Dietary Pattern: A Prospective Cohort Study. [PDF]

Nutrients
Tranidou A, Siargkas A, Magriplis E, Tsakiridis I, Kripouri P, Apostolopoulou A, Chourdakis M, Dagklis T.   +7 more
europepmc   +1 more source

Clinical characteristics and in‐hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open‐loop era: A UK‐wide MINAP registry analysis

Diabetic Medicine, EarlyView.
Abstract Background We compared characteristics of adults with insulin‐treated diabetes using continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections (MDI) during admission with acute coronary syndrome (ACS) and identified factors associated with in‐hospital mortality among CSII users.
Harshal Deshmukh, Moosa Shaikh, Emma G. Wilmot, Eric Kilpatrick, Sudipta Chattopadhyay, Thozhukat Sathyapalan, Joseph John   +6 more
wiley   +1 more source

Glycemic load impacts the response of acquired resistance in breast cancer cells to chemotherapeutic drugs in vitro. [PDF]

PLoS One
Adham SA, Al Kalbani A, Al Zeheimi N, Al Dalali M, Al Kharusi N, Siddiqi A, Al Maskari A.   +6 more
europepmc   +1 more source

Effect of Glycemic Index and Glycemic Load on Atherosclerotic Stenosis and Stroke

Journal of Atherosclerosis and Thrombosis, 2020
Yuan, Min, Zhou, Huang-Yan
openaire   +3 more sources

Subgroups of Adult‐Onset Diabetes: A Prospective Follow‐Up Study of Progression of Insulin Resistance and Deficiency and Association With Liver Steatosis and Fibrosis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To assess progression of insulin deficiency and resistance in diabetes, the stability of cluster‐based subgrouping, and the association between steatotic liver disease (SLD), liver fibrosis (LF), and tissue insulin resistance. Materials and Methods Participants from a regional diabetes register were studied within 3 years from diagnosis ...
Aleksi Laitinen, Annemari Käräjämäki, Aki J. Käräjämäki, Samu Kurki, Liisa Hakaste, Olof Asplund, Johan Hultman, Kaj Lahti, Mikko Lehtovirta, Emma Ahlqvist, Tiinamaija Tuomi   +10 more
wiley   +1 more source

Glycemic index and glycemic load of brief sugary sweets: randomized controlled trials of eight Thai desserts. [PDF]

Front Nutr
Namjud N, Senaprom S, Ondee T, Bumrungpert A, Heath J, Pongpirul K.   +5 more
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Mental Health Disorders in Type 2 Diabetes: Active Comparator, New User Cohort Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims We evaluated the risk of mental health disorders among glucagon‐like peptide‐1 receptor agonist (GLP1RA) users compared with users of dipeptidyl peptidase‐4 (DPP‐4) inhibitors and sodium‐glucose cotransporter‐2 (SGLT2) inhibitors. Materials and Methods We conducted a nationwide, active‐comparator new‐user cohort study using the Korean ...
Chungsoo Kim, Seonji Kim, Dong Yun Lee, Eugene Han, Yong‐ho Lee, Seng Chan You   +5 more
wiley   +1 more source

Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study. [PDF]

Front Nutr
Scully KJ, Truex L, Brennan A, Fowler R, Sawicki GS, Uluer A, Ludwig DS, Ebbeling CB, Langlais L, Dziok A, Freedman SD, Putman MS.   +11 more
europepmc   +1 more source

Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Tirzepatide is a once‐weekly glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonist (RA) approved for weight management in adults with obesity. Data on older adults remain limited, however. This study aimed to examine tirzepatide's safety and efficacy in adults aged ≥ 65 years with obesity ...
Nasreen Alfaris, Robert F. Kushner, Jianghao Li, Kevin L. Chen, Mia Fenimore, Boris Calderon, Adam Stefanski   +6 more
wiley   +1 more source